Herpes zoster ophthalmicus (HZO) occurs when the varicella-zoster virus, the same virus behind chickenpox, reactivates in the ophthalmic branch of the trigeminal nerve and attacks the eye and surrounding tissues. Roughly half of people with HZO develop some form of ocular disease, and up to a quarter of those go on to have chronic or recurrent problems.1PubMed Central. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention The condition is far more than a painful rash near the eye; it can threaten vision, damage corneal nerves, and even raise the risk of stroke.
Why the Virus Targets the Eye
After a childhood bout of chickenpox, the varicella-zoster virus does not leave your body. It retreats into nerve clusters called ganglia and stays dormant, sometimes for decades. When immunity weakens, whether from aging, immunosuppressive medications, chronic disease, or other stressors, the virus can flare back to life.2PubMed Central. Herpes Zoster Ophthalmicus: A Devastating Disease Coming Back with Vengeance or Finding Its Nemesis? The trigeminal nerve, the main sensory nerve of the face, has three major branches. The topmost branch, the ophthalmic division, supplies sensation to the forehead, upper eyelid, and cornea. When the virus reactivates specifically in this branch, the resulting shingles episode tracks along those nerve fibers to the skin of the forehead and, critically, to structures in and around the eye.
Herpes zoster affects somewhere between 20% and 30% of the population over a lifetime, and roughly 10% to 20% of those cases involve the ophthalmic division.3PubMed. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity People who are older or immunocompromised are particularly vulnerable. One case series documented severe trigeminal zoster in a 57-year-old woman on immunosuppressant drugs, where the infection spread across multiple branches of the trigeminal nerve, underscoring how quickly the disease can escalate when immune defenses are thin.4PubMed Central. Trigeminal herpes zoster: early recognition and treatment are crucial
Hutchinson’s Sign and What It Means
One of the most clinically useful warning signs in HZO is Hutchinson’s sign: blisters or sores appearing on the tip or side of the nose. That patch of skin is supplied by the nasociliary nerve, a small branch of the ophthalmic division that also sends fibers into the eye itself. When the virus is active enough to reach the nose tip, it has almost certainly reached the eye as well. A study evaluating this sign found that it roughly tripled the risk of ocular inflammation and quadrupled the risk of corneal nerve damage.5PubMed. Prognostic value of Hutchinson’s sign in acute herpes zoster ophthalmicus When blisters appeared on the skin supplied by both branches of the nasociliary nerve, every single patient in the study developed ocular inflammation.
This is why clinicians treat nose-tip involvement as an alarm bell. A 77-year-old woman presenting with ophthalmic zoster and nasal tip blisters was found to have eyelid swelling, conjunctival injection, pus, and early corneal damage on examination, illustrating the kind of ocular picture Hutchinson’s sign predicts.6PubMed Central. Hutchinson’s sign of ophthalmic zoster If you notice blisters on the forehead that extend to the nose tip, getting to an ophthalmologist quickly can make a real difference in outcome. That said, the absence of Hutchinson’s sign does not mean the eye is safe; ocular involvement still occurs in many patients without it.
What Happens Inside the Eye
The range of ocular complications in HZO is remarkably broad, and they tend to unfold in a sequence over weeks to months. An early study tracking corneal complications found that the most common initial problems were punctate keratitis (tiny erosions on the corneal surface) and pseudodendrites, each appearing in about half of patients. Deeper corneal involvement followed: stromal infiltrates in about 41% of cases, inflammation affecting both the cornea and the inner eye (kerato-uveitis) in about a third, and neurotrophic keratitis, where corneal nerves lose function, in about a quarter.7PubMed. Corneal complications from herpes zoster ophthalmicus More serious but less common problems included serpiginous ulceration and disciform keratitis.
The common ocular manifestations, conjunctivitis, keratitis, and uveitis, are treatable in most patients. But rarer complications like optic neuropathy and retinitis carry a higher threat to vision.8PubMed Central. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention The virus can also affect the cranial nerves that control eye movement. In one documented case, a 78-year-old man developed complete oculomotor nerve palsy, with a drooping eyelid, dilated pupil, and inability to move the eye normally, all on the same side as his shingles rash.9PubMed Central. Herpes zoster ophthalmicus-induced oculomotor nerve palsy Eye movement palsies from HZO typically improve over months, but they can be frightening and disorienting while they last.
Corneal Nerve Damage and Its Fallout
One of the most insidious consequences of HZO is the damage it inflicts on the corneal nerves. Using high-resolution microscopy to track corneal nerve changes over time, researchers found a significant drop in corneal nerve fiber density and branching within the first two months after the HZO episode. By six months, nerve density had recovered to near-baseline levels, suggesting the acute damage is partly reversible.10PubMed Central. Corneal nerve changes in herpes zoster ophthalmicus: a prospective longitudinal in vivo confocal microscopy study But “partly” is the key word. In some patients, nerve function never fully returns.
When corneal nerves fail to recover, the result is neurotrophic keratopathy, a condition where the cornea loses its ability to sense irritation and heal itself. Without normal nerve signaling, the corneal surface breaks down, leading to persistent sores that resist treatment. A large study found that neurotrophic keratopathy developed in about 7% of HZO patients, with the highest risk window falling one to two years after the initial shingles episode.11Cornea. Neurotrophic Keratopathy After Herpes Zoster Ophthalmicus This delayed onset catches some people off guard; they assume the worst is over once the rash heals, only to develop corneal problems a year later.
The long-term corneal risk goes beyond neurotrophic keratopathy. A large database study found that HZO patients were roughly four and a half times more likely to develop corneal ulcers compared to matched controls, even after adjusting for other risk factors like diabetes and contact lens use.12PubMed Central. Association between herpes zoster ophthalmicus and the risk of corneal ulcer This elevated risk underscores why ophthalmologic follow-up should continue well beyond the acute phase of the illness.
Postherpetic Neuralgia
The most common and often most debilitating complication of shingles, regardless of where it occurs on the body, is postherpetic neuralgia (PHN), persistent nerve pain that continues after the rash resolves. When PHN involves the trigeminal nerve, the pain can radiate across the forehead, around the eye, and into the scalp. Trigeminal PHN is considered one of the most challenging locations for this type of pain, involving not just peripheral nerve injury but alterations in how the brain processes pain signals.13PubMed Central. Trigeminal Postherpetic Neuralgia: From Pathophysiology to Treatment
The main risk factor for developing PHN is age. Older adults are far more likely to develop persistent pain than younger people. Other risk factors include the severity of the initial rash, intense pain during the acute episode, and whether the eye itself was involved.14PubMed. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity The pain can be burning, stabbing, or constant, and it is notoriously difficult to manage. Standard painkillers often do not work well; treatment typically involves medications designed for nerve pain, such as gabapentin or pregabalin, and sometimes nerve blocks. For many patients, PHN is what transforms HZO from a serious but time-limited illness into a chronic condition that affects daily life for months or years.
The Stroke Connection
An aspect of herpes zoster that surprises many people is its link to stroke. When the virus reactivates in the trigeminal nerve, it can spread to the cerebral arteries and directly damage blood vessel walls, a process called VZV vasculopathy. This vascular remodeling can narrow arteries and promote clot formation. Multiple large epidemiological studies across different countries have confirmed that herpes zoster, particularly involving the ophthalmic branch, is an independent risk factor for stroke.15PubMed Central. The relationship between herpes zoster and stroke The risk appears to be highest in the weeks and months immediately following the shingles episode, and there is evidence that antiviral treatment may reduce it. This vascular risk is one more reason that prompt antiviral therapy matters in HZO.
Antiviral Treatment
Starting antiviral medication within 72 hours of the rash appearing is the standard of care for HZO. The evidence for early treatment is convincing. A study of 86 patients treated promptly with oral acyclovir found that late ocular inflammatory complications appeared in about 29% of them at six months, compared to rates of 50% to 71% reported in untreated patients in other studies.16PubMed. Oral acyclovir for herpes zoster ophthalmicus That reduction extends not just to eye complications but also to the severity of the skin eruption and the intensity of postherpetic neuralgia.
Valacyclovir, a newer antiviral that the body converts into acyclovir, has a simpler dosing schedule (three times daily rather than five) and achieves higher drug levels. However, a Cochrane systematic review comparing the two drugs head-to-head in HZO found essentially no difference in ocular complication rates. Conjunctivitis occurred in about half of both groups, punctate keratitis in roughly 40% to 48%, and dendritic keratitis in 11% of each group.17Cochrane Database of Systematic Reviews. Valacyclovir compared with acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients The practical upshot is that valacyclovir is often preferred for convenience, but acyclovir works just as well for the eye. In cases where the optic nerve itself is threatened, oral valacyclovir has been used successfully to treat optic neuritis in otherwise healthy patients, sometimes avoiding the need for intravenous hospital treatment.18PubMed Central. Oral Valacyclovir Treatment of Herpes Zoster Ophthalmicus-Induced Optic Neuritis
Beyond antivirals, topical corticosteroid eye drops are used when the cornea develops deeper inflammation (stromal keratitis) or when the iris and inner structures of the eye become inflamed (uveitis). These need to be prescribed and monitored by an ophthalmologist, because steroids in the eye can raise pressure and promote secondary infection if used improperly. The steroid dose is tapered gradually based on the clinical response, sometimes over weeks or months.19PubMed Central. Managing ophthalmic herpes zoster in primary care
How Age and Immune Status Change the Picture
HZO does not look the same in everyone. A comparative study of patients older and younger than 60 found that postherpetic neuralgia, neurotrophic keratopathy, and secondary bacterial keratitis were all more frequent in the older group. Younger patients, on the other hand, had more frequent pseudodendrites and a higher rate of recurrent flares per year.20PubMed. Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years Rates of more structural complications like corneal perforation, thinning, cataract formation, and glaucoma were similar between age groups. In other words, older patients tend to suffer more from the nerve-related aftermath, while younger patients may deal with more recurrent surface inflammation.
Immune status makes an even bigger difference than age alone. A study of young adults with HZO compared HIV-positive and HIV-negative patients and found stark contrasts. Among the HIV-negative group, 90% achieved good final vision of 20/40 or better, and only 10% developed postherpetic neuralgia. In the HIV-positive group, every patient ended up with vision of 20/200 or worse. A quarter of HIV-positive patients developed secondary bacterial keratitis from their damaged corneal surface, and three-quarters developed postherpetic neuralgia. Permanent scarring and lid deformities were found exclusively in the HIV-positive group.21PubMed Central. Herpes Zoster Ophthalmicus: Disease Spectrum in Young Adults These findings reinforce that immune function is the single most important variable in determining how severe HZO becomes.
Zoster Without a Rash
There is a diagnostic trap that even experienced clinicians can fall into: zoster sine herpete, which is varicella-zoster virus reactivation without the typical skin rash. A patient shows up with eye pain, redness, and anterior uveitis, but no blisters anywhere on the face. Without the telltale rash, the diagnosis can be missed or delayed. A published case described bilateral ocular involvement from zoster sine herpete, where characteristic iris atrophy provided the clue. The authors recommended that when a patient presents with anterior uveitis and iris atrophy, especially if it is unexplained, testing the fluid inside the eye for varicella-zoster virus DNA can confirm the diagnosis rapidly.22PubMed. Zoster sine herpete with bilateral ocular involvement This is a diagnosis that requires active suspicion on the clinician’s part; waiting for a rash that will never come means losing valuable treatment time.
When Surgery Becomes Necessary
Most HZO cases are managed medically, but severe or chronic corneal damage sometimes requires surgical intervention. Corneal transplantation, whether full-thickness (penetrating keratoplasty) or partial-thickness, is performed when scarring is dense enough to block vision or when the cornea perforates. One study followed 14 keratoplasties in HZO patients and found that while all grafts remained clear at the final evaluation, the postoperative course was frequently complicated. The most common issues were persistent surface breakdown from ongoing nerve damage and severe dry eye, occurring in over half of grafted eyes. Graft rejection occurred in about a third. Still, about 43% of eyes achieved corrected vision of 20/40 or better, and about 64% reached 20/100 or better.23PubMed. Long-term results of keratoplasty in patients with herpes zoster ophthalmicus These are respectable numbers for what are often very compromised eyes, but they also illustrate why preventing severe corneal damage through early and sustained medical treatment is the preferred strategy.
The Role of the Shingles Vaccine
The recombinant zoster vaccine (Shingrix) has been shown to be effective at preventing herpes zoster ophthalmicus itself.24The Ocular Surface. Effectiveness of adult zoster vaccination in preventing a first episode of zoster keratitis: A large-scale database study Shingrix is a two-dose vaccine recommended for adults 50 and older, as well as for immunocompromised adults 19 and older. Clinical trials showed it to be more than 90% effective at preventing shingles in older adults, a dramatic improvement over the older live-attenuated vaccine (Zostavax), which has been discontinued in many markets. By preventing shingles outbreaks from occurring in the first place, the vaccine sidesteps the entire cascade of ocular complications, postherpetic neuralgia, and vascular risk described throughout this article.
Whether the vaccine specifically prevents the downstream complication of zoster keratitis, once HZO has already occurred, has not been directly established. The evidence so far addresses prevention of the triggering episode itself rather than modification of its complications. For people who have already had HZO, the vaccine may still reduce the chance of a recurrence, though guidance on timing relative to an acute episode varies. The clearest message from the data is that vaccination before the first episode occurs is the most effective way to avoid HZO and everything that comes with it.
Recurrent Episodes and Monitoring
One misconception about HZO is that it is a one-time event. While many people have a single episode, recurrences happen, and younger patients in particular tend to experience more frequent flares of corneal inflammation per year than older patients.25PubMed. Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years Chronic or recurrent ocular disease develops in up to a quarter of those whose eyes are affected.26PubMed Central. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention These flares can appear months or even years after the original rash, sometimes triggered by steroid taper or stress.
Because of this drawn-out timeline, ophthalmologic monitoring after HZO often extends well beyond the acute illness. The window of highest risk for neurotrophic keratopathy is one to two years out, corneal ulcer risk remains elevated long-term, and subtle recurrences of stromal inflammation can be easy to miss without a slit-lamp examination. If you have had HZO, staying connected with an eye specialist for periodic checks, even when everything seems fine, is a practical step that can catch problems before they erode vision.